...
首页> 外文期刊>Biochimica et biophysica acta. Molecular cell research >Implication of Nrf2 and ATF4 in differential induction of CHOP by proteasome inhibition in thyroid cancer cells
【24h】

Implication of Nrf2 and ATF4 in differential induction of CHOP by proteasome inhibition in thyroid cancer cells

机译:Nrf2和ATF4在蛋白酶体抑制甲状腺癌细胞CHOP差异诱导中的意义

获取原文
获取原文并翻译 | 示例

摘要

Proteasome inhibition may cause endoplasmic reticulum (ER) stress, which has been reported to be implicated in the antitumoral effects of proteasome inhibitors. CCAAT/enhancer-binding protein homologous protein (CHOP) is induced by a variety of adverse physiological conditions including ER stress and is involved in apoptosis. We have reported that distinct induction of CHOP contributes to the responsiveness of thyroid cancer cells to proteasome inhibitors. However, the mechanism underlying differential induction of CHOP by proteasome inhibitors in thyroid cancer cells has not been well characterized. In the current study, we characterized that proteasome inhibition primarily activated the amino acid response element 1 (AARE1) on the CHOP promoter. We also demonstrated that although proteasome inhibition caused similar accumulation of activating transcription factor 4 (ATF4) in a panel of thyroid cancer cells, distinct amounts of ATF4 were recruited to the AARE1 element of CHOP promoter. In addition, we demonstrated that NF-E2-related factor 2 (Nrf2) was also implicated in the induction of CHOP by precluding the binding of ATF4 to the CHOP promoter. This study highlights the molecular mechanisms by which ATF4 and Nrf2 can control CHOP induction in thyroid cancer cells by proteasome inhibition.
机译:蛋白酶体抑制作用可能引起内质网(ER)应激,据报道这与蛋白酶体抑制剂的抗肿瘤作用有关。 CCAAT /增强子结合蛋白同源蛋白(CHOP)是由包括ER应激在内的多种不利生理条件诱导的,并参与细胞凋亡。我们已经报道了CHOP的不同诱导有助于甲状腺癌细胞对蛋白酶体抑制剂的响应性。但是,蛋白酶体抑制剂在甲状腺癌细胞中差异诱导CHOP的机制尚未得到很好的表征。在当前的研究中,我们表征了蛋白酶体抑制作用主要激活了CHOP启动子上的氨基酸反应元件1(AARE1)。我们还证明,尽管蛋白酶体抑制作用在一组甲状腺癌细胞中引起类似的活化转录因子4(ATF4)积累,但不同数量的ATF4被募集到CHOP启动子的AARE1元件中。另外,我们通过排除ATF4与CHOP启动子的结合,证明了NF-E2相关因子2(Nrf2)也参与了CHOP的诱导。这项研究强调了ATF4和Nrf2可以通过蛋白酶体抑制来控制甲状腺癌细胞CHOP诱导的分子机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号